Dyno Therapeutics is a biotechnology company specializing in the development of artificial intelligence-empowered vectors aimed at revolutionizing gene therapy. By leveraging advanced technologies and forging strategic partnerships, Dyno seeks to create transformative gene therapies that can significantly improve the lives of millions. The company employs a diverse team that includes molecular biologists, synthetic biologists, protein engineers, and data scientists, who collaborate to innovate and enhance the design of gene therapy capsids. With recognition as a leading startup in the biotech sector, Dyno continues to pursue its mission of unlocking the potential of gene therapy through cutting-edge science and technology.